Uterine Fibroids (Leiomyomas)

Uterine Fibroids (Leiomyomas) is the indication for 5 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as: Leiomyoma · Uterine Fibroids · Uterine Leiomyomas · Fibroid · Uterine Leiomyoma
Classified under: Musculoskeletal and Connective Tissue Diseases
Neoplasms
Urogenital Diseases
Indicated drugs: Elagolix
Estradiol
Leuprolide
Norethisterone
Relugolix

Resolves to

Vocabularies

MeSHM0012316ICD-10D25SNOMED CT1162890002MedDRA10016628UMLSC0023267

What you can answer from here — as of September 29, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

206Clinical trialsPhase, status and sponsor resolved per trial

1Contraindicated drugDrugs whose labels contraindicate them in this condition

5Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Uterine Fibroids (Leiomyomas) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.